Scholarly publications and presentations by Rochester Regional Health's Infectious Diseases department authors.
Submissions from 2022
8-30-2022 A Simple Walk in the Park...Or is it? Lyme Disease, Michael Mancenido, Rochester Regional Health
7-19-2022 Monkeypox, Anja Bottler, Rochester Regional Health
6-17-2022 Rates of Medically Attended RSV among US Adults: A Systematic Review and Meta-Analysis, John M. McLaughlin, Pfizer Vaccines, Collegeville, PA, USA, Farid Khan, Pfizer Vaccines, Collegeville, PA, USA, Elizabeth Begier, Pfizer Vaccines, Collegeville, PA, USA, et al.
6-15-2022 Phase 1/2 Randomized Study of the Immunogenicity, Safety and Tolerability of an RSV Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine, Ann R. Falsey, Rochester Regional Health; Edward E. Walsh, Rochester Regional Health; and Daniel A. Scott, Vaccine Research and Development, Pfizer Inc, Collegeville, PA, 19426 USA.
5-15-2022 Go V.I.R.A.L.: Social Media Engagement Strategies in Infectious Diseases, Bradley J. Langford, Public Health Ontario, Toronto, Ontario, Canada., Maryrose Laguio-Vila, Rochester Regional Health, Timothy P. Gauthier, Baptist Health South Florida Clinical Pharmacy Enterprise, Miami, Florida, USA., et al.
4-15-2022 A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine, Edward E. Walsh, Rochester Regional Health; Ann R. Falsey, Rochester Regional Health; and Daniel A. Scott, Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
3-24-2022 Antimicrobial Stewardship Opportunities in Hospitalized Patients with Febrile Neutropenia, Carlos Portales Castillo, Rochester Regional Health and Maryrose R. Laguio-Vila, Rochester Regional Health
3-15-2022 Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2020, Angela R. Branche, University of Rochester; Edward E. Walsh, Rochester Regional Health; and Ann R. Falsey, Rochester Regional Health
3-1-2022 Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York, Emil Lesho, Rochester Regional Health, Brendan Corey, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, Francois Lebreton, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, et al.
1-22-2022 Effectiveness of various cleaning strategies in acute and long-term care facilities during novel corona virus 2019 disease pandemic-related staff shortages, Emil Lesho, Rochester Regional Health, Donna Newhart, Rochester Regional Health, Lisa Reno, Rochester Regional Health, et al.
1-18-2022 COVID-19: Medication Update, Anja Bottler, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
1-6-2022 COVID, Emil P. Lesho, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Maryrose Laguio-Vila, Rochester Regional Health
1-2022 Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire, Ann R. Falsey, Rochester Regional Health, Edward E. Walsh, Rochester Regional Health, Richard H. Osborne, Department of Health and Medical Sciences, Swinburne University of Technology, Melbourne, Victoria, Australia., et al.
1-1-2022 Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019, Yoonyoung Choi, Merck & Co., Inc., Alexandra Hill-Ricciuti, Columbia University Irving Medical Center, Angela R. Branche, University of Rochester, et al.
Submissions from 2021
12-28-2021 A systems genomics approach uncovers molecular associates of RSV severity, Matthew N. McCall, Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester New York, United States of America., Chin-Yi Chu, Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, University of Rochester Medical Center, Rochester New York, United States of America., Lu Wang, Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester New York, United States of America., et al.
12-16-2021 Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine, Ann R. Falsey, Rochester Regional Health, Magdalena E. Sobieszczyk, Ian Hirsch, et al.
12-10-2021 A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development, Francois Lebreton, Walter Reed Army Institute of Research, Erik Snesrud, Walter Reed Army Institute of Research, Mary Hinkle, Rochester Regional Health, et al.
11-12-2021 Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells, Shuya Kyu, Emory University School of Medicine, Richard P. Ramonell, Emory University School of Medicine, Merin Kuruvilla, Emory University School of Medicine, et al.
11-1-2021 Pneumonia, Sinusitis, Influenza and Other Respiratory Illnesses in Acute Otitis Media-Prone Children, Michael E. Pichichero, Rochester Regional Health; Timothy J. Chapman, Rochester Regional Health; and Peter Bajorski, Rochester Institute of Technology
11-1-2021 Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza-Related Hospitalizations in Adults-A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study), Ann R. Falsey, Rochester Regional Health, Edward E. Walsh, Rochester Regional Health, Stacey House, Washington University School of Medicine, St Louis, Missouri, USA., et al.
10-26-2021 Transition of Serotype 35B Pneumococci From Commensal to Prevalent Virulent Strain in Children, Naoko Fuji, Rochester Regional Health, Michael Pichichero, Rochester Regional Health, Rachel L. Ehrlich, Drexel University College of Medicine, et al.
10-21-2021 COVID Update, Maryrose Laguio-Vila, Rochester Regional Health; Emil P. Lesho, Rochester Regional Health; and Edward E. Walsh, Rochester Regional Health
10-18-2021 Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial, Andre C. Kalil, University of Nebraska Medical Center, Omaha, NE, USA., Aneesh K. Mehta, Emory University, Atlanta, GA, USA., Thomas F. Patterson, University of Texas Health San Antonio, University Health System, and the South Texas Veterans Health Care System, San Antonio, TX, USA., et al.
9-13-2021 COVID-19 Pandemic Impact on Respiratory Infectious Diseases in Primary Care Practice in Children, Ravinder Kaur, Rochester Regional Health, Steven Schulz, Rochester Regional Health, Naoko Fuji, Rochester Regional Health, et al.
9-1-2021 Nasopharyngeal microbiome composition associated with Streptococcus pneumoniae colonization suggests a protective role of Corynebacterium in young children, Lei Xu, Rochester Regional Health; Joshua Earl, Drexel University College of Medicine; and Michael E. Pichichero, Rochester Regional Health